This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (388)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Topic Collections  • Quality of Care  • Evidence-Based Medicine  • Review  • Genetics  • Genetic Disorders  • Alert me on articles by topic  Social Bookmarking   What's this?

MTHFR 677CT Polymorphism and Risk of Coronary Heart Disease

A Meta-analysis

Mariska Klerk, MSc; Petra Verhoef, PhD; Robert Clarke, MD; Henk J. Blom, PhD; Frans J. Kok, PhD; Evert G. Schouten, MD, PhD; and the MTHFR Studies Collaboration Group

JAMA. 2002;288:2023-2031.

Context  In observational studies, individuals with elevated levels of plasma homocysteine tend to have moderately increased risk of coronary heart disease (CHD). The MTHFR 677CT polymorphism is a genetic alteration in an enzyme involved in folate metabolism that causes elevated homocysteine concentrations, but its relevance to risk of CHD is uncertain.

Objective  To assess the relation of MTHFR 677CT polymorphism and risk of CHD by conducting a meta-analysis of individual participant data from all case-control observational studies with data on this polymorphism and risk of CHD.

Data Sources  Studies were identified by searches of the electronic literature (MEDLINE and Current Contents) for relevant reports published before June 2001 (using the search terms MTHFR and coronary heart disease), hand searches of reference lists of original studies and review articles (including meta-analyses) on this topic, and contact with investigators in the field.

Study Selection  Studies were included if they had data on the MTHFR 677CT genotype and a case-control design (retrospective or nested case-control) and involved CHD as an end point. Data were obtained from 40 (34 published and 6 unpublished) observational studies involving a total of 11 162 cases and 12 758 controls.

Data Extraction  Data were collected on MTHFR 677CT genotype, case-control status, and plasma levels of homocysteine, folate, and other cardiovascular risk factors. Data were checked for consistency with the published article or with information provided by the investigators and converted into a standard format for incorporation into a central database. Combined odds ratios (ORs) for the association between the MTHFR 677CT polymorphism and CHD were assessed by logistic regression.

Data Synthesis  Individuals with the MTHFR 677 TT genotype had a 16% (OR, 1.16; 95% confidence interval [CI], 1.05-1.28) higher odds of CHD compared with individuals with the CC genotype. There was significant heterogeneity between the results obtained in European populations (OR, 1.14; 95% CI, 1.01-1.28) compared with North American populations (OR, 0.87; 95% CI, 0.73-1.05), which might largely be explained by interaction between the MTHFR 677CT polymorphism and folate status.

Conclusions  Individuals with the MTHFR 677 TT genotype had a significantly higher risk of CHD, particularly in the setting of low folate status. These results support the hypothesis that impaired folate metabolism, resulting in high homocysteine levels, is causally related to increased risk of CHD.

Author Affiliations: Division of Human Nutrition and Epidemiology, Wageningen University (Ms Klerk and Drs Verhoef, Kok, and Schouten), and Wageningen Centre for Food Sciences (Ms Klerk and Dr Verhoef), Wageningen, the Netherlands; Clinical Trial Service Unit, Radcliffe Infirmary, Oxford, England (Dr Clarke); and the Laboratory of Pediatrics and Neurology, University Medical Center Nijmegen, Nijmegen, the Netherlands (Dr Blom).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLES

Homocysteine and Risk of Ischemic Heart Disease and Stroke: A Meta-analysis
Homocysteine Studies Collaboration
JAMA. 2002;288(16):2015-2022.
ABSTRACT | FULL TEXT  

Homocysteine and Coronary Heart Disease: How Great Is the Hazard?
Peter W. F. Wilson
JAMA. 2002;288(16):2042-2043.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Genome-wide significant predictors of metabolites in the one-carbon metabolism pathway
Hazra et al.
Hum Mol Genet 2009;18:4677-4687.
ABSTRACT | FULL TEXT  

Evaluating the causal relevance of diverse risk markers: horizontal systematic review
Kuper et al.
BMJ 2009;339:b4265-b4265.
ABSTRACT | FULL TEXT  

Major Depression and Coronary Flow Reserve Detected by Positron Emission Tomography
Vaccarino et al.
Arch Intern Med 2009;169:1668-1676.
ABSTRACT | FULL TEXT  

Identification of ZNF366 and PTPRD as novel determinants of plasma homocysteine in a family-based genome-wide association study
Malarstig et al.
Blood 2009;114:1417-1422.
ABSTRACT | FULL TEXT  

Does the MTHFR 677C->T variant affect the Recommended Dietary Allowance for folate in the US population?
Robitaille et al.
Am. J. Clin. Nutr. 2009;89:1269-1273.
ABSTRACT | FULL TEXT  

Regulation of homocysteine homeostasis through the transcriptional coactivator PGC-1{alpha}
Li et al.
Am. J. Physiol. Endocrinol. Metab. 2009;296:E543-E548.
ABSTRACT | FULL TEXT  

Homocysteine and Depression in Later Life
Almeida et al.
Arch Gen Psychiatry 2008;65:1286-1294.
ABSTRACT | FULL TEXT  

Sport-related hyperhomocysteinaemia: a putative marker of muscular demand to be noted for cardiovascular risk
Borrione et al.
Br. J. Sports. Med. 2008;42:894-900.
ABSTRACT | FULL TEXT  

Gene-environment interactions reveal a homeostatic role for cholesterol metabolism during dietary folate perturbation in mice
Kitami et al.
Physiol. Genomics 2008;35:182-190.
ABSTRACT | FULL TEXT  

Hyperhomocysteinemia and Lower Extremity Wounds
Schwartzfarb and Romanelli
INT J LOW EXTREM WOUNDS 2008;7:126-136.
ABSTRACT  

Murine Models of Hyperhomocysteinemia and Their Vascular Phenotypes
Dayal and Lentz
Arterioscler. Thromb. Vasc. Bio. 2008;28:1596-1605.
ABSTRACT | FULL TEXT  

Genetic Predisposition, Nongenetic Risk Factors, and Coronary Infarct
Trichopoulou et al.
Arch Intern Med 2008;168:891-896.
ABSTRACT | FULL TEXT  

Folate, Vitamin B6, Vitamin B12, and Methionine Intakes and Risk of Stroke Subtypes in Male Smokers
Larsson et al.
Am J Epidemiol 2008;167:954-961.
ABSTRACT | FULL TEXT  

Cardiac Autonomic Dysfunction: Effects From Particulate Air Pollution and Protection by Dietary Methyl Nutrients and Metabolic Polymorphisms
Baccarelli et al.
Circulation 2008;117:1802-1809.
ABSTRACT | FULL TEXT  

Lowering Plasma Homocysteine Concentrations of Older Men and Women with Folate, Vitamin B-12, and Vitamin B-6 Does Not Affect the Proportion of (n-3) Long Chain Polyunsaturated Fatty Acids in Plasma Phosphatidylcholine
Crowe et al.
J. Nutr. 2008;138:551-555.
ABSTRACT | FULL TEXT  

Meta- and Pooled Analyses of the Methylenetetrahydrofolate Reductase C677T and A1298C Polymorphisms and Gastric Cancer Risk: A Huge-GSEC Review
Boccia et al.
Am J Epidemiol 2008;167:505-516.
ABSTRACT | FULL TEXT  

Homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease--results of the renal Hope-2 study
Mann et al.
Nephrol Dial Transplant 2008;23:645-653.
ABSTRACT | FULL TEXT  

B Vitamins for the Prevention of Vascular Disease: Insufficient Evidence to Justify Treatment
Baigent and Clarke
JAMA 2007;298:1212-1214.
FULL TEXT  

Summary of the American Heart Association's Scientific Statement on the Relevance of Genetics and Genomics for Prevention and Treatment of Cardiovascular Disease
Arnett and for the Writing Group
Arterioscler. Thromb. Vasc. Bio. 2007;27:1682-1686.
FULL TEXT  

The heritability of plasma homocysteine, and the influence of genetic variation in the homocysteine methylation pathway
Siva et al.
QJM 2007;100:495-499.
ABSTRACT | FULL TEXT  

High frequency of vitamin B12 deficiency in asymptomatic individuals homozygous to MTHFR C677T mutation is associated with endothelial dysfunction and homocysteinemia
Zittan et al.
Am. J. Physiol. Heart Circ. Physiol. 2007;293:H860-H865.
ABSTRACT | FULL TEXT  

Relevance of Genetics and Genomics for Prevention and Treatment of Cardiovascular Disease: A Scientific Statement From the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group
Arnett et al.
Circulation 2007;115:2878-2901.
ABSTRACT | FULL TEXT  

Homocysteine and Cardiovascular Risk: Considering the Evidence in the Context of Study Design, Folate Fortification, and Statistical Power
Ueland and Clarke
Clin. Chem. 2007;53:807-809.
FULL TEXT  

Lowering Homocysteine with B Vitamins Has No Effect on Blood Pressure in Older Adults
McMahon et al.
J. Nutr. 2007;137:1183-1187.
ABSTRACT | FULL TEXT  

Genetic Effects versus Bias for Candidate Polymorphisms in Myocardial Infarction: Case Study and Overview of Large-Scale Evidence
Ntzani et al.
Am J Epidemiol 2007;165:973-984.
ABSTRACT | FULL TEXT  

Homocysteine, 5,10-Methylenetetrahydrofolate Reductase 677C>T Polymorphism, Nutrient Intake, and Incident Cardiovascular Disease in 24 968 Initially Healthy Women
Zee et al.
Clin. Chem. 2007;53:845-851.
ABSTRACT | FULL TEXT  

Nonvalidation of Reported Genetic Risk Factors for Acute Coronary Syndrome in a Large-Scale Replication Study
Morgan et al.
JAMA 2007;297:1551-1561.
ABSTRACT | FULL TEXT  

Effect of MTHFR C677T genotype on survival in type 2 diabetes patients with end-stage diabetic nephropathy
Boger et al.
Nephrol Dial Transplant 2007;22:154-162.
ABSTRACT | FULL TEXT  

Elevated Prenatal Homocysteine Levels as a Risk Factor for Schizophrenia
Brown et al.
Arch Gen Psychiatry 2007;64:31-39.
ABSTRACT | FULL TEXT  

Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: a randomized, placebo-controlled, double-blind trial
den Heijer et al.
Blood 2007;109:139-144.
ABSTRACT | FULL TEXT  

Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence
Wald et al.
BMJ 2006;333:1114-1117.
FULL TEXT  

Alleviating the Burden of Cancer: A Perspective on Advances, Challenges, and Future Directions.
Schottenfeld and Beebe-Dimmer
Cancer Epidemiol. Biomarkers Prev. 2006;15:2049-2055.
ABSTRACT | FULL TEXT  

Stromelysin-1 5A/6A and eNOS T-786C Polymorphisms, MTHFR C677T and A1298C Mutations, and Cigarette-Cannabis Smoking: A Pilot, Hypothesis-Generating Study of Gene-Environment Pathophysiological Associations With Buerger's Disease
Glueck et al.
CLIN APPL THROMB HEMOST 2006;12:427-439.
ABSTRACT  

Interaction of homocysteine and conventional predisposing factors on risk of ischaemic stroke in young people: consistency in phenotype-disease analysis and genotype-disease analysis
Pezzini et al.
J. Neurol. Neurosurg. Psychiatry 2006;77:1150-1156.
ABSTRACT | FULL TEXT  

Homocysteine Hypothesis for Atherothrombotic Cardiovascular Disease: Not Validated
Kaul et al.
J Am Coll Cardiol 2006;48:914-923.
ABSTRACT | FULL TEXT  

Insight into the nature of the CRP-coronary event association using Mendelian randomization
Casas et al.
Int J Epidemiol 2006;35:922-931.
ABSTRACT | FULL TEXT  

Response to Letter Regarding Article, "Riboflavin Lowers Homocysteine in Individuals Homozygous for the MTHFR 677C->T Polymorphism"
McNulty et al.
Circulation 2006;114:e66-e66.
FULL TEXT  

Vitamins and entacapone in levodopa-induced hyperhomocysteinemia: A randomized controlled study
Postuma et al.
Neurology 2006;66:1941-1943.
ABSTRACT | FULL TEXT  

The Many Facets of Hyperhomocysteinemia: Studies from the Framingham Cohorts
Selhub
J. Nutr. 2006;136:1726S-1730S.
ABSTRACT | FULL TEXT  

The Hordaland Homocysteine Study: A Community-Based Study of Homocysteine, Its Determinants, and Associations with Disease
Refsum et al.
J. Nutr. 2006;136:1731S-1740S.
ABSTRACT | FULL TEXT  

Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease
The Heart Outcomes Prevention Evaluation (HOPE) 2
NEJM 2006;354:1567-1577.
ABSTRACT | FULL TEXT  

Maternal MTHFR 677C>T is a risk factor for congenital heart defects: effect modification by periconceptional folate supplementation
van Beynum et al.
Eur Heart J 2006;27:981-987.
ABSTRACT | FULL TEXT  

Interactions among polymorphisms in folate-metabolizing genes and serum total homocysteine concentrations in a healthy elderly population
Devlin et al.
Am. J. Clin. Nutr. 2006;83:708-713.
ABSTRACT | FULL TEXT  

Methylenetetrahydrofolate Reductase Polymorphisms and Homocysteine-Lowering Effect of Vitamin Therapy in Singaporean Stroke Patients
Ho et al.
Stroke 2006;37:456-460.
ABSTRACT | FULL TEXT  

Riboflavin Lowers Homocysteine in Individuals Homozygous for the MTHFR 677C->T Polymorphism
McNulty et al.
Circulation 2006;113:74-80.
ABSTRACT | FULL TEXT  

The Glycine N-Methyltransferase (GNMT) 1289 C->T Variant Influences Plasma Total Homocysteine Concentrations in Young Women after Restricting Folate Intake
Beagle et al.
J. Nutr. 2005;135:2780-2785.
ABSTRACT | FULL TEXT  

The choice of a genetic model in the meta-analysis of molecular association studies
Minelli et al.
Int J Epidemiol 2005;34:1319-1328.
ABSTRACT | FULL TEXT  

JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice
Prepared by: British Cardiac Society, British Hype
Heart 2005;91:v1-v52.
FULL TEXT  

Homocysteine and Its Effects on In-Stent Restenosis
De Luca et al.
Circulation 2005;112:e307-e311.
FULL TEXT  

Meta-analysis of MTHFR 677C->T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate?
Lewis et al.
BMJ 2005;331:1053.
ABSTRACT | FULL TEXT  

Assessment of Hemostatic Risk Factors in Predicting Arterial Thrombotic Events
Feinbloom and Bauer
Arterioscler. Thromb. Vasc. Bio. 2005;25:2043-2053.
ABSTRACT | FULL TEXT  

A high-protein diet increases postprandial but not fasting plasma total homocysteine concentrations: a dietary controlled, crossover trial in healthy volunteers
Verhoef et al.
Am. J. Clin. Nutr. 2005;82:553-558.
ABSTRACT | FULL TEXT  

Review: Diabetes and cardiac disease in South Asians
Mukhopadhyay et al.
British Journal of Diabetes & Vascular Disease 2005;5:253-259.
ABSTRACT  

Cerebral Vascular Dysfunction in Methionine Synthase-Deficient Mice
Dayal et al.
Circulation 2005;112:737-744.
ABSTRACT | FULL TEXT  

Polymorphisms in Cytoplasmic Serine Hydroxymethyltransferase and Methylenetetrahydrofolate Reductase Affect the Risk of Cardiovascular Disease in Men
Lim et al.
J. Nutr. 2005;135:1989-1994.
ABSTRACT | FULL TEXT  

Alcohol intake and methylenetetrahydrofolate reductase polymorphism modify the relation of folate intake to plasma homocysteine
Chiuve et al.
Am. J. Clin. Nutr. 2005;82:155-162.
ABSTRACT | FULL TEXT  

Homocysteine and MTHFR Mutations: Relation to Thrombosis and Coronary Artery Disease
Varga et al.
Circulation 2005;111:e289-e293.
FULL TEXT  

Conditional Risk Factors for Atherosclerosis
Kullo and Ballantyne
Mayo Clin Proc. 2005;80:219-230.
ABSTRACT  

Hyperhomocysteinemic Diabetic Cardiomyopathy: Oxidative Stress, Remodeling, and Endothelial-Myocyte Uncoupling
Tyagi et al.
J CARDIOVASC PHARMACOL THER 2005;10:1-10.
ABSTRACT  

Methylenetetrahydrofolate reductase polymorphism (C677T), hyperhomocysteinemia, and risk of ischemic cardiovascular disease and venous thromboembolism: prospective and case-control studies from the Copenhagen City Heart Study
Frederiksen et al.
Blood 2004;104:3046-3051.
ABSTRACT | FULL TEXT  

Folate levels determine effect of antioxidant supplementation on micronuclei in subjects with cardiovascular risk
Smolkova et al.
Mutagenesis 2004;19:469-476.
ABSTRACT | FULL TEXT  

Meta-analysis of Genetic Studies in Ischemic Stroke: Thirty-two Genes Involving Approximately 18 000 Cases and 58 000 Controls
Casas et al.
Arch Neurol 2004;61:1652-1661.
ABSTRACT | FULL TEXT  

Genetic Basis of Atherosclerosis: Part II: Clinical Implications
Lusis et al.
Circulation 2004;110:2066-2071.
FULL TEXT  

Phenotypic expression of the methylenetetrahydrofolate reductase 677C->T polymorphism and flavin cofactor availability in thyroid dysfunction
Hustad et al.
Am. J. Clin. Nutr. 2004;80:1050-1057.
ABSTRACT | FULL TEXT  

Homocysteine and levodopa: Should Parkinson disease patients receive preventative therapy?
Postuma and Lang
Neurology 2004;63:886-891.
ABSTRACT | FULL TEXT  

Dietary serine and cystine attenuate the homocysteine-raising effect of dietary methionine: a randomized crossover trial in humans
Verhoef et al.
Am. J. Clin. Nutr. 2004;80:674-679.
ABSTRACT | FULL TEXT  

Bioavailability of polyglutamyl folic acid relative to that of monoglutamyl folic acid in subjects with different genotypes of the glutamate carboxypeptidase II gene
Melse-Boonstra et al.
Am. J. Clin. Nutr. 2004;80:700-704.
ABSTRACT | FULL TEXT  

An Integrated Approach to the Meta-Analysis of Genetic Association Studies using Mendelian Randomization
Minelli et al.
Am J Epidemiol 2004;160:445-452.
ABSTRACT | FULL TEXT  

Hyperhomocysteinemia in Patients with Cushing's Syndrome
Terzolo et al.
J. Clin. Endocrinol. Metab. 2004;89:3745-3751.
ABSTRACT | FULL TEXT  

Folic Acid-Based Multivitamin Therapy to Prevent Stroke: The Jury Is Still Out
Hankey and Eikelboom
Stroke 2004;35:1995-1998.
FULL TEXT  

Established and Emerging Plasma Biomarkers in the Prediction of First Atherothrombotic Events
Ridker et al.
Circulation 2004;109:IV-6-IV-19.
FULL TEXT  

5,10-methylenetetrahydrofolate reductase (MTHFR) 677C->T and 1298A->C mutations are associated with DNA hypomethylation
Castro et al.
J. Med. Genet. 2004;41:454-458.
FULL TEXT  

A healthy lifestyle lowers homocysteine, but should we care?
Verhoef and Katan
Am. J. Clin. Nutr. 2004;79:713-714.
FULL TEXT  

Effect of Mthfr genotype on diet-induced hyperhomocysteinemia and vascular function in mice
Devlin et al.
Blood 2004;103:2624-2629.
ABSTRACT | FULL TEXT  

Cross-talk between Cys34 and Lysine Residues in Human Serum Albumin Revealed by N-Homocysteinylation
Glowacki and Jakubowski
J. Biol. Chem. 2004;279:10864-10871.
ABSTRACT | FULL TEXT  

Polymorphisms in Genes Involved in Folate Metabolism and Colorectal Neoplasia: A HuGE Review
Sharp and Little
Am J Epidemiol 2004;159:423-443.
ABSTRACT | FULL TEXT  

Commentary: Mendelian randomization, 18 years on
Katan
Int J Epidemiol 2004;33:10-11.
FULL TEXT  

Mendelian randomization: prospects, potentials, and limitations
Smith and Ebrahim
Int J Epidemiol 2004;33:30-42.
FULL TEXT  

Facts and Recommendations about Total Homocysteine Determinations: An Expert Opinion
Refsum et al.
Clin. Chem. 2004;50:3-32.
ABSTRACT | FULL TEXT  

Red cell N5-methyltetrahydrofolate concentrations and C677T methylenetetrahydrofolate reductase genotype in patients with stroke
Icke et al.
J. Clin. Pathol. 2004;57:54-57.
ABSTRACT | FULL TEXT  

The atherogenic effect of excess methionine intake
Troen et al.
Proc. Natl. Acad. Sci. USA 2003;100:15089-15094.
ABSTRACT | FULL TEXT  

Controlled Modulation of Folate Polyglutamyl Tail Length by Metabolic Engineering of Lactococcus lactis
Sybesma et al.
Appl. Environ. Microbiol. 2003;69:7101-7107.
ABSTRACT | FULL TEXT  

Low Dose Betaine Supplementation Leads to Immediate and Long Term Lowering of Plasma Homocysteine in Healthy Men and Women
Olthof et al.
J. Nutr. 2003;133:4135-4138.
ABSTRACT | FULL TEXT  

Homocysteine Status and Polymorphisms of Methylenetetrahydrofolate Reductase Are Not Associated With Restenosis After Stenting in Coronary Arteries
Koch et al.
Arterioscler. Thromb. Vasc. Bio. 2003;23:2229-2234.
ABSTRACT | FULL TEXT  

Age and Gender Affect the Relation between Methylenetetrahydrofolate Reductase C677T Genotype and Fasting Plasma Homocysteine Concentrations in the Framingham Offspring Study Cohort
Russo et al.
J. Nutr. 2003;133:3416-3421.
ABSTRACT | FULL TEXT  

Colon Cancer and Genetic Variation in Folate Metabolism: The Clinical Bottom Line
Little et al.
J. Nutr. 2003;133:3758S-3766.
ABSTRACT | FULL TEXT  

Homocysteine and the Risk of Intrauterine Growth Retardation
Cattaneo
Clin. Chem. 2003;49:1432-1433.
FULL TEXT  

The Use of B Vitamin Supplements and Peripheral Arterial Disease Risk in Men Are Inversely Related
Merchant et al.
J. Nutr. 2003;133:2863-2867.
ABSTRACT | FULL TEXT  

Elevated Plasma Homocysteine Was Associated With Hemorrhagic and Ischemic Stroke, but Methylenetetrahydrofolate Reductase Gene C677T Polymorphism Was a Risk Factor for Thrombotic Stroke: A Multicenter Case-Control Study in China
Li et al.
Stroke 2003;34:2085-2090.
ABSTRACT | FULL TEXT  

Emerging Risk Factors for Atherosclerotic Vascular Disease: A Critical Review of the Evidence
Hackam and Anand
JAMA 2003;290:932-940.
ABSTRACT | FULL TEXT